A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Clinical trial NCT04288687 · COMPLETED
Trial details
- NCT number
- NCT04288687
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2024-02-20
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.